Impact of breast cancer–related lymphedema on working women

Vignes, S.; Fau-Prudhomot, Pascal; Simon, Laura; Sanchez-Bréchot, Marie-Laure; Arrault, M.; Locher, Fabrice

doi:10.1007/s00520-019-04804-2

Cited by 25 publications

(20 citation statements)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…We note recent studies focusing on BCRL economic burden and return-to-work issues [ 41 , 42 •, 43 – 47 , 48 •], and few studies addressing sexuality concerns [ 27 – 29 ], and body image and self-esteem [ 23 – 26 ]. An interesting finding in this review is the number of reports identifying continued challenges among those with BCRL in receiving education about BCRL and their perceptions about health care providers’ abilities to meet their psychosocial care needs [ 50 – 56 , 57 •].…”

Section: Discussionmentioning

confidence: 99%

“…BCRL can significantly impact employment and limit return-to-work [ 41 , 42 •]. The cascading nature of the economic burden on long-term savings and work opportunities, and insufficiency of insurance to cover lymphedema needs drove financial differences [ 43 ].…”

Section: Psychosocial Issues In Bcrlmentioning

confidence: 99%

“…However, reduced work engagement and ability, employment status, and work performance are associated with a combination of individual factors, work environment, culture, and resources [ 48 •]. Thus, occupational physicians should assess BCRL-attributed difficulties to improve working conditions [ 42 •] which includes modifying physical work conditions [ 47 ] to accommodate the physical needs of individuals working with physical limitations secondary to BCRL [ 48 •].…”

Section: Psychosocial Issues In Bcrlmentioning

confidence: 99%

See 2 more Smart Citations

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

Eaton

Narkthong

Hulett

2020

Curr Breast Cancer Rep

View full text Add to dashboard Cite

Purpose of Review Breast cancer-related lymphedema (BCRL) is a chronic disease affecting breast cancer survivors. The purpose of this article is to update the scientific literature regarding psychosocial issues associated with BCRL. Recent Findings Reports describe economic burdens, social support, sexuality, BCRL patient-education needs, and interventions to reduce BCRL symptoms and improve QOL among women with breast cancer. The psychosocial impact of BCRL may differ between younger and older women which has implications for age-related interventions to reduce the adverse psychosocial experiences of women with BCRL. We did not locate studies reporting the psychosocial impact of BCRL on male breast cancer survivors. Summary More psychosocial-based interventions are needed that target the concerns of those with BCRL, including age-related needs, sexual concerns, body image, and social support. Future research is indicated to study the psychosocial impact of BCRL among men. Researchers may consider how pandemic-driven health care policies affect the psychosocial needs of those with BCRL.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Psychosocial Issues In Bcrlmentioning

confidence: 99%

Section: Psychosocial Issues In Bcrlmentioning

confidence: 99%

See 1 more Smart Citation

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

Eaton

Narkthong

Hulett

2020

Curr Breast Cancer Rep

View full text Add to dashboard Cite

show abstract

“…As a result, the number of women living with the long-term effects of breast cancer treatment grows, making the quality of survivorship more relevant. Between 8% and 56% of breast cancer survivors develop arm or shoulder problems such as restricted shoulder mobility, shoulder pain and lymphoedema,1–6 with one of the most underestimated and debilitating morbidities of them all being upper limb lymphoedema.…”

Section: Introductionmentioning

confidence: 99%

“…Limb swelling may present with symptoms of heaviness, tightness, pain and loss of normal arm function and range of motion. The negative psychological effects brought on by the impairments of activities in daily life and reduced limb aesthetics constitute an additional burden and decrease in health-related quality of life (HRQoL) 1 7 11 13 21. Moreover, infections of the skin are regularly seen in a severe stadium of lymphoedema, such as erysipelas or cellulitis 2 8 21…”

Section: Introductionmentioning

confidence: 99%

Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial

et al. 2020

View full text Add to dashboard Cite

IntroductionEarly breast cancer detection and advancements in treatment options have resulted in an increase of breast cancer survivors. An increasing number of women are living with the long-term effects of breast cancer treatment, making the quality of survivorship an increasingly important goal. Breast cancer-related lymphoedema (BCRL) is one of the most underestimated complications of breast cancer treatment with a reported incidence of 20%. A microsurgical technique called lymphaticovenous anastomosis (LVA) might be a promising treatment modality for patients with BCRL. The main objective is to assess whether LVA is more effective than the current standard therapy (conservative treatment) in terms of improvement in quality of life and weather it is cost-effective.Methods and analysisA multicentre, randomised controlled trial, carried out in two academic and two community hospitals in the Netherlands. The study population includes 120 women over the age of 18 who have undergone treatment for breast cancer including axillary treatment (sentinel lymph node biopsy or axillary lymph node dissection) and/or axillary radiotherapy, presenting with an early stage lymphoedema of the arm, viable lymphatic vessels and received at least 3 months conservative treatment. Sixty participants will undergo the LVA operation and the other sixty will continue their regular conservative treatment, both with a follow-up of 24 months. The primary outcome is the health-related quality of life. Secondary outcomes are societal costs, quality adjusted life years, cost-effectiveness ratio, discontinuation rate of conservative treatment and excess limb volume.Ethics and disseminationThe study was approved by the Ethics Committee of Maastricht University Medical Center (METC) on 19 December 2018 (NL67059.068.18). The results of this study will be disseminated in presentations at academic conferences, publications in peer-reviewed journals and other news media.Trial registration numberNCT02790021; Pre-results.

show abstract

Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial

Gennaro

Maccauro

Mariani

et al. 2022

Cancer

View full text Add to dashboard Cite

Background:The need for axillary dissection (AD) is declining, but it is still essential for many patients with nodal involvement who risk developing breast-cancerrelated lymphedema (BCRL) with lifelong consequences. Previous nonrandomized studies found axillary reverse mapping and selective axillary dissection (ARM-SAD) a safe and feasible way to preserve the arm's lymphatic drainage. Methods:The present two-arm prospective randomized clinical trial was held at a single comprehensive cancer center to ascertain whether ARM-SAD can reduce the risk of BCRL, compared with standard AD, in patients with node-positive breast cancer. Whatever the type of breast surgery or adjuvant treatments planned, 130 patients with nodal involvement met our inclusion criteria: 65 were randomized for AD and 65 for ARM-SAD. Twelve months after surgery, a physiatrist assessed patients for BCRL and calculated the excess volume of the operated arm. Lymphoscintigraphy was used to assess drainage impairment. Self-reports of any impairment were also recorded. Results:The difference in the incidence of BCRL between the two groups was 21% (95% CI, 3-37; p = .03). A significantly lower rate of BCRL after ARM-SAD was confirmed by a multimodal analysis that included the physiatrist's findings, excess arm volume, and lymphoscintigraphic findings, but this was not matched by a significant difference in patients' self-reports. Conclusions:Our findings encourage a change of surgical approach when AD is still warranted. ARM-SAD may be an alternative to standard AD to reduce the treatment-related morbidity.

show abstract

Impact of breast cancer–related lymphedema on working women

Cited by 25 publications

References 32 publications

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

Psychosocial Issues Associated with Breast Cancer-Related Lymphedema: a Literature Review

Improving the quality of life of patients with breast cancer-related lymphoedema by lymphaticovenous anastomosis (LVA): study protocol of a multicentre randomised controlled trial

Occurrence of breast‐cancer–related lymphedema after reverse lymphatic mapping and selective axillary dissection versus standard surgical treatment of axilla: A two‐arm randomized clinical trial

Contact Info

Product

Resources

About